Last reviewed · How we verify

NCT04787406

Motor Learning and tDCS in Parkinson's Disease

Completed NA Last updated 26 August 2021
What this trial tests

NA trial testing Transcranial direct current stimulation in Parkinson Disease in 33 participants. Completed in 27 September 2019.

Timeline
7 January 2019
Primary endpoint
27 September 2019
27 September 2019

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment33
Start date7 January 2019
Primary completion27 September 2019
Estimated completion27 September 2019
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 40 to 80, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study sought to examine the efficacy of single session transcranial direct current stimulation applied over the primary motor cortex in people with Parkinson's disease on sequential motor learning performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04787406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing